Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

JiangSu QianRong Assets Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 18
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 16
Rounds per year 1.50
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.11
Exits 2
Key employees Soon

Areas of investment

  • Hardware
  • Electronics
  • Construction
  • Commercial Real Estate
  • Real Estate
Summary

The main office of represented VC is situated in the Suzhou. The fund was located in Asia if to be more exact in China.

The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Autonomous Vehicles, Electronics. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight PayEgis, CGeneTech, Jia.com.

This JiangSu QianRong Assets Management works on 9 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The higher amount of exits for fund were in 2018. The top activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The average startup value when the investment from JiangSu QianRong Assets Management is 100-500 millions dollars.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the JiangSu QianRong Assets Management, startups are often financed by Tianyi Group, PreIPO, Legend Capital. The meaningful sponsors for the fund in investment in the same round are Oriza Holdings, Tongren Boda, Suzhou Yipu Equity Investment Fund Management Co. In the next rounds fund is usually obtained by Oriza Holdings, Orchid Asia Group Management, Jianxin Capital.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Ample Harvest Finance China, Shanghai
CKM Capital Partners Ann Arbor, Michigan, United States
Culture Convenience Club (CCC) Japan, Tokyo
EquipmentShare Columbia, Missouri, United States
Fink Family Foundation -
Guolian Securities Anhui, China, Wuxi
Hongyou Chuangye Touzi Chengguan District, China, Lhasa
Hua Hsia Investment Holding Co Taipei, Taiwan
IESE Business School Barcelona, Catalonia, Spain
Interscope Records California, Santa Monica, United States
Lazerow Ventures New York, New York, United States
Magnetik New York, New York, United States
MTGx Stockholm, Stockholm County, Sweden
Now Capital Delhi, India, New Delhi
u2i -
Vertex Ventures US California, Palo Alto, United States
Wechsler & Co. Mount Kisco, New York, United States
Zeus Health -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Youwei Image

Artificial Intelligence
Information Technology
Software
31 Aug 2023 Suzhou, Jiangsu, China

Wanguiyuan Precision Medical

Manufacturing
Medical
Medical Device
26 Apr 2022 Suzhou, Jiangsu, China

RealWear

Hardware
Wearables
$18M18 Nov 2021 Xian Shi, Shaanxi, China

Jieyanxin

Consumer Electronics
Electronics
Manufacturing
Sensor
$7M09 Nov 2021 Suzhou, Jiangsu, China

Tsingtech Microvision

Automotive
Electronics
$1M06 May 2019 Gusu District, Jiangsu, China

Anzhi Automotive Parts

Automotive
Autonomous Vehicles
Industrial Automation
15 Apr 2019 Suzhou, Jiangsu, China

Hardware
$231K31 Jan 2019 China, Anhui

BayNexus

Information Services
Internet of Things
Medical
$4M16 Jul 2018 Wuxi City, Jiangsu, China

CGeneTech

Biopharma
Biotechnology
Health Care
Pharmaceutical
$15M13 Dec 2017 Gusu District, Jiangsu, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent JiangSu QianRong Assets Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 18
Average round size 5M
Rounds per year 1.50
Peak activity year 2019
Lead investments 3
Follow on index 0.11
Exits 2
Group Appearance index 0.78

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Youwei Image

Artificial Intelligence
Information Technology
Software
31 Aug 2023 Suzhou, Jiangsu, China

Wanguiyuan Precision Medical

Manufacturing
Medical
Medical Device
26 Apr 2022 Suzhou, Jiangsu, China

RealWear

Hardware
Wearables
$18M18 Nov 2021 Xian Shi, Shaanxi, China

Jieyanxin

Consumer Electronics
Electronics
Manufacturing
Sensor
$7M09 Nov 2021 Suzhou, Jiangsu, China

Tsingtech Microvision

Automotive
Electronics
$1M06 May 2019 Gusu District, Jiangsu, China

Anzhi Automotive Parts

Automotive
Autonomous Vehicles
Industrial Automation
15 Apr 2019 Suzhou, Jiangsu, China

Hardware
$231K31 Jan 2019 China, Anhui

BayNexus

Information Services
Internet of Things
Medical
$4M16 Jul 2018 Wuxi City, Jiangsu, China

CGeneTech

Biopharma
Biotechnology
Health Care
Pharmaceutical
$15M13 Dec 2017 Gusu District, Jiangsu, China
Crunchbase icon

Content report

The following text will be sent to our editors: